Leukocyte-nanomedicine system for targeted delivery and precise theragnostics

X. Li, Y. Lu, L.D. Kong, X.Y. Shi*, A. Pich*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

Targeted delivery of nanomedicines to disease sites via living cell carriers has attracted extensive attention, but a better way to direct nanomedicines to carriers is still under exploration. Recently in Nature Nanotechnology, Cruz et al. modified the binding peptides on nanomedicines to hitchhike with specifically activated leukocytes for improved therapy of venous thrombosis.
Original languageEnglish
Pages (from-to)2591-2593
Number of pages3
JournalChem
Volume8
Issue number10
DOIs
Publication statusPublished - 13 Oct 2022

Keywords

  • INFLAMMATION

Fingerprint

Dive into the research topics of 'Leukocyte-nanomedicine system for targeted delivery and precise theragnostics'. Together they form a unique fingerprint.

Cite this